secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-09-15T13:10:08+00:00
Accession:  0001193125-26-391415
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health announces 1-for-15 reverse stock split effective Sept 17, 2026
----------------------------------------------------------------------------

- 1-for-15 reverse split effective 12:01 am ET Sept 17, 2026; trading begins split-adjusted on Nasdaq under JAGX.
- Split approved by stockholders at April 20, 2026 special meeting; board set exact ratio at 1-for-15.
- Purpose is to support compliance with Nasdaq listing standards (minimum bid price requirement).
- New CUSIP 47010C854; no fractional shares—cash paid in lieu; Equiniti Trust Company acts as exchange agent.
- Outstanding options, warrants, and equity plan reserves adjusted proportionately; par value unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526391415/0001193125-26-391415-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526391415/d105876d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-391415

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer